Biotech Values

[rkrw]

Your "quickly supplanted" part. Your doomsday scenario is years away. How many patients will be treated between now and then? How much cash flow to the first movers? What will the hcv market level out at once the first waves of patients get treated? What will the hcv treatment paradigm look like 7 years from now when an ACHN, assuming everything goes perfectly well gets approved?